Skip to content

Taxes Paid at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$11.66M+16,554%
United Therapeutics logo
United TherapeuticsUTHR
$1.5M+200%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.63B-2.6%
Insmed logo
InsmedINSM
$2.94M+35.1%
Incyte logo
IncyteINCY
Immunovant, Inc. logo
Immunovant, Inc.IMVT

Other financials

Income statement

See full
Revenue$56.4M+99.0%
Operating income-$3.6M+81.1%
Net income$3.8M+132%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$193.7M+38.7%
Total debt$9.8M-13.9%
Total equity$655.5M-4.9%
Total assets$697.5M-6.0%

Cash flow

See full
Operating cash flow-$48.9M-139%
CapEx$215.0K-60.6%
Free cash flow-$49.2M-139%

Valuation

See full
Market cap$7.26B+127%
Enterprise value$7.07B+130%
P/S98×+82.6×

Profitability

See full
Operating margin-192.4%-205pp
Net margin-154.9%-182pp
FCF margin-12,264.3%-12,527pp

Returns & leverage

See full
Return on equity-17.1%-26.1pp
Debt / equity0.0×
Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Protagonist Therapeutics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Protagonist Therapeutics's taxes paid?
Protagonist Therapeutics (PTGX) reported taxes paid of $923.5K in Q4 2025.
How has Protagonist Therapeutics's taxes paid changed year-over-year?
Protagonist Therapeutics's taxes paid increased by 141.4% year-over-year, from $382.5K to $923.5K.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.